We have team of well-rounded and experienced scientist and pioneers strive to push the boundaries of current scientific research and explore the possibility of novel therapeutics for cancer and chronic inflammation.
To achieve this goal, Convergen builds its unique database covering information from frontier scientific discoveries, clinical practice as well as industry know-how. Driven by the database, Convergen team bridges collaboration between scientists, industry professionals, and investors for translation of pioneer sciences.
We have constructed a pipeline of targeted oncology therapeutics and programs that are diversified by mechanism, therapeutic approach, modality, and stage of development. Welcome to contact our team for collaborations from different perspectives.
Current pipeline of Convergen （dated Aug.5, 2021)